Journal
RESPIRATION
Volume 101, Issue 3, Pages 281-290Publisher
KARGER
DOI: 10.1159/000519751
Keywords
Cystic fibrosis; Children; Bronchodilator intervention study; Lung function; Lung clearance index; Functional magnetic resonance imaging
Categories
Funding
- Swiss Cystic Fibrosis Foundation (CFCH)
- Batzebar Foundation of the Children's University Hospital Bern, Switzerland
- Swiss national science foundation (SNF) [182719]
Ask authors/readers for more resources
The study comprehensively assessed the functional response to nebulized inhalation with salbutamol in children with cystic fibrosis (CF). It was found that inhalation of salbutamol led to improved FEV1 and reduced ventilation inhomogeneity in CF patients. However, there were heterogeneous responses among patients, suggesting the need for individual spirometry testing to predict therapeutic effects.
Background: Inhalation therapy is one of the cornerstones of the daily treatment regimen in patients with cystic fibrosis (CF). Recommendations regarding the addition of bronchodilators, especially salbutamol are conflicting due to the lack of evidence. New diagnostic measures such as multiple-breath washout (MBW) and functional magnetic resonance imaging (MRI) have the potential to reveal new insights into bronchodilator effects in patients with CF. Objective: The objective of the study was to comprehensively assess the functional response to nebulized inhalation with salbutamol in children with CF. Methods: Thirty children aged 6-18 years with stable CF performed pulmonary function tests, MBW, and matrix pencil-MRI before and after standardized nebulized inhalation of salbutamol. Results: Lung clearance index decreased (improved) by -0.24 turnover (95% confidence interval [CI]: -0.53 to 0.06; p = 0.111). Percentage of the lung volume with impaired fractional ventilation and relative perfusion decreased (improved) by -0.79% (CI: -1.99 to 0.42; p = 0.194) and -1.31% (CI: -2.28 to -0.35; p = 0.009), respectively. Forced expiratory volume (FEV1) increased (improved) by 0.41 z-score (CI: 0.24-0.58; p < 0.0001). We could not identify specific clinical factors associated with a more pronounced effect of salbutamol. Conclusions: There is a positive short-term effect of bronchodilator inhalation on FEV1 in patients with CF, which is independent of ventilation inhomogeneity. Heterogeneous response between patients suggests that for prediction of a therapeutic effect this should be tested by spirometry in every patient individually.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available